SelectQuote Secures Multiyear PBM Deal for SelectRx Pharmacy
Event summary
- SelectQuote's SelectRx pharmacy signed a multiyear agreement with a significant PBM partner, effective January 1, 2026.
- The deal enhances financial predictability and aligns with Q1 2026 earnings guidance.
- SelectRx serves over 100,000 Medicare beneficiaries with chronic conditions across 50 states.
- CEO Tim Danker highlighted improved reimbursement visibility and clinical value recognition.
The big picture
This agreement underscores SelectQuote's strategic pivot toward healthcare services, complementing its core insurance distribution business. The deal comes amid broader industry shifts toward value-based care and integrated health solutions, positioning SelectRx to capitalize on Medicare's growing focus on chronic condition management. With over 100,000 members, SelectRx's scale and adherence metrics could become key differentiators in an increasingly consolidated PBM landscape.
What we're watching
- Reimbursement Stability
- How the new PBM agreement will affect SelectRx's long-term financial consistency and growth.
- Operational Focus
- Whether the refinancing with Pathlight and UMB will allow SelectQuote to accelerate its healthcare services expansion.
- Market Positioning
- The pace at which SelectRx can leverage its high-touch model to maintain competitive advantage in Medicare pharmacy services.
Related topics